T21RS Press Release regarding COVID-19 Vaccine Safety in Individuals with Down Syndrome

Using new data from an ongoing survey of COVID-19 in people with Down syndrome aged 12 and older, the Trisomy 21 research society (T21RS) shares the results of that data regarding the safety of vaccines in these individuals.

Click to visit the T21RS Statement Regarding COVID Vaccine Safety